188 related articles for article (PubMed ID: 9535997)
1. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.
Ferrari P; Torielli L; Ferrandi M; Padoani G; Duzzi L; Florio M; Conti F; Melloni P; Vesci L; Corsico N; Bianchi G
J Pharmacol Exp Ther; 1998 Apr; 285(1):83-94. PubMed ID: 9535997
[TBL] [Abstract][Full Text] [Related]
2. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
4. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin.
Manunta P; Ferrandi M; Messaggio E; Ferrari P
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):61-6. PubMed ID: 16529550
[TBL] [Abstract][Full Text] [Related]
5. Ouabain antagonists as antihypertensive agents.
Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P
Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857
[TBL] [Abstract][Full Text] [Related]
6. PST 2238 as an antihypertensive compound that antagonizes the effect of endogenous cardiac glycosides.
Winnicka K; Tomasiak M
Acta Pol Pharm; 2005; 62(1):75-9. PubMed ID: 16022498
[TBL] [Abstract][Full Text] [Related]
7. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G
Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940
[TBL] [Abstract][Full Text] [Related]
8. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'.
Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G
Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814
[TBL] [Abstract][Full Text] [Related]
9. 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action.
Quadri L; Bianchi G; Cerri A; Fedrizzi G; Ferrari P; Gobbini M; Melloni P; Sputore S; Torri M
J Med Chem; 1997 May; 40(11):1561-4. PubMed ID: 9171865
[No Abstract] [Full Text] [Related]
10. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive compounds that modulate the Na-K pump.
Ferrari P; Ferrandi M; Torielli L; Barassi P; Tripodi G; Minotti E; Molinari I; Melloni P; Bianchi G
Ann N Y Acad Sci; 2003 Apr; 986():694-701. PubMed ID: 12763920
[TBL] [Abstract][Full Text] [Related]
12. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
Ferrari P
Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196
[TBL] [Abstract][Full Text] [Related]
13. Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension.
Ferrandi M; Molinari I; Bianchi G; Ferrari P
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):15-8. PubMed ID: 17535730
[TBL] [Abstract][Full Text] [Related]
14. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
15. PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats.
Ferrandi M; Barassi P; Minotti E; Duzzi L; Molinari I; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 2002 Dec; 40(6):881-9. PubMed ID: 12451321
[TBL] [Abstract][Full Text] [Related]
16. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
[TBL] [Abstract][Full Text] [Related]
18. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
19. Increased heart microsomal Na(+) K(+)-transporting ATPase activity by tetrandrine in spontaneously hypertensive rats.
Chen NH; Wang YL; Ding JH
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):320-5. PubMed ID: 8249625
[TBL] [Abstract][Full Text] [Related]
20. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
Tal DM; Karlish SJ
Mol Pharmacol; 1988 Sep; 34(3):245-9. PubMed ID: 2843743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
